• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Sagent Launches Phase 2 Trial to Evaluate Camostat Mesilate for COVID-19 americanpharmaceuticalreview
    November 24, 2020
    Sagent Pharmaceuticals, a Nichi-Iko Group Company, has launched its Phase 2 CAMELOT trial to evaluate the safety and efficacy of Camostat Mesilate (Camostat) for the treatment of COVID-19 in high-risk outpatients and has begun enrolling patients.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service